Clinical Trial Update: Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy. [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating risperidone added to standard therapy versus placebo in adults with generalized anxiety disorder who respond sub-optimally t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anxiety Disorders | Phase 3 | Status: COMPLETED